Overview
Janashakthi Insurance is a Sri Lankan life and health insurer, with earnings also shaped by the investment portfolio that supports policyholder obligations. The central change is a sharp weakening in the latest September quarter after a much stronger comparable period, rather than an improvement in the operating picture.
Price performance
At LKR 40.30 on 13 November 2026, the share rose 24.8% over one month against a 10.3% ASPI gain, but remained down 21.2% over one year while the ASPI fell 4.7%. The recent rebound therefore follows a materially weaker longer record than the market.
The price sat 36.2% of the way through its 52-week range, and the share has recorded four falls of 15% or more in three years, the deepest 42% and not yet recovered. Liquidity is limited: a LKR 1 million order is about 85% of what trades on a typical day, a large part of a day's trading. The April 2026 one-for-three subdivision tripled the share count but did not change the size of the business; adjusted returns account for that mechanical change.
Valuation
The P/E of 8.5 times means the market price is LKR 8.50 for each LKR 1 of trailing profit, and it ranks at the 13th percentile among insurance peers with available P/E data. That is inexpensive relative to the sector, but the trailing profit base substantially predates the weak September result: the latest quarter supplied only 3.5% of trailing EPS, and the same price would equate to 3.8 times earnings had that quarter retained its year-ago margin.
The P/B of 1.63 means LKR 1.63 is paid for each LKR 1 of net assets. It is more expensive than 70% of days since January 2019, so the share is cheap on earnings relative to peers but not cheap against its own book-value record. ROE was 20.8% for the audited year ended December 2025, which helps explain a P/B above the sector median. The 8.3% dividend yield is supported by a 69.9% payout and 1.43 times dividend cover; dividends recorded were LKR 5.00 per share in FY2025 and LKR 4.41 in FY2023, with no FY2024 payment recorded in the supplied history.
News and sentiment
Direct company coverage is thin, with two material articles in the past 90 days. An article reported on 14 August that first-half 2026 gross written premiums grew 36% to LKR 5.1 billion and profit before tax was LKR 271 million; this predates the weaker September-quarter filing. The only later item, on 3 November, concerned a director-status reclassification and was routine.
Financials
For the September 2026 quarter, revenue fell 30.4% year-on-year to LKR 3.0 billion and net profit fell 98.1% to LKR 28.7 million from LKR 1.5 billion. The profit a share represents in the latest quarter was therefore far smaller than a year earlier, not merely diluted by the April subdivision.
Gross and operating margins are not available for the September filing. Net margin was 1.0%, versus 34.3% a year earlier; this was among the worst of the seven September quarters on record, ranking sixth of seven. The comparable figures are on the same company basis, so the contraction is like-for-like.
Equity fell to LKR 16.8 billion from LKR 18.5 billion a year earlier. Shares outstanding were 679.6 million at September, versus 226.5 million before the one-for-three split; per-share figures across that event are mechanical unless restated, so the absolute profit decline is the more meaningful result.
Risks
The principal risk is the scale of the earnings reversal: September net profit was only LKR 28.7 million after a LKR 1.5 billion comparable-quarter result. A 1.0% net margin means that modest movements in insurance, investment or claims outcomes can materially change the profit available to ordinary shareholders.
As an insurer, the relevant leverage measure is liabilities against equity. This stood at 1.43 times at December 2025, up from 1.24 times a year earlier, meaning the business carried LKR 1.43 of liabilities, including policyholder obligations, for every LKR 1 of equity. Falling government bond yields affect returns on new fixed-income placements and valuations of bond holdings across the insurance sector, but the supplied data cannot isolate Janashakthi's portfolio sensitivity.
Trading liquidity is a separate practical risk because a LKR 1 million order represents about 85% of median daily turnover. The 2025 second interim dividend is also no longer attached to the shares: its 24 December 2025 ex-date has passed.
Outlook
The next evidence point is the audited year ending 31 December 2026, expected to be filed between 28 April and 3 June 2027. As at 14 November 2026, that filing will show whether the September earnings collapse was offset elsewhere in the year or marks a broader reset in profitability. It will also update equity and the insurer's liability base; current data cannot separate the contribution of underwriting, claims and investment income to the September decline.